Treatment-free remission after second-line nilotinib treatment in patients with chronic myeloid leukemia in chronic phase: results from a single-group, phase 2, open-label study

Nom du journal : Ann Intern Med

Année : 2018

Volume : 168

Page de départ : 461

Page de fin : 470

Auteurs: Dengler J, Sacha T, Wong S, Moiraghi B, Kim DW, Nicolini FE, Hughes TP, Lipton JH, Mahon FX, Boquimpani C, Benyamini N, Clementino NCD, Shuvaev V, Ailawadhi S, Turkina AG, De Paz R, Takahashi N, Fellague-Chebra R, Acharya S, Jin Y,